InsiderTrades

Form 4 for RLMD RELMADA THERAPEUTICS, INC.

Accepted 2025-05-20 00:00:00 ET · period of report 2025-05-16 · accession 0001213900-25-046085 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2025-05-20 2025-05-16+ RLMD TRAVERSA SERGIO CEO, Dir P - Purchase $0.5007 +350.0K 556.3K +170% +$175.2K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-19 P A 30,000 $0.5 586,338 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F3) Purchase prices range from $0.4998 to $0.50 per share, inclusive.
2 Common Common Stock 2025-05-20 P A 147,686 $0.56 734,024 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F4) Purchase prices range from $0.53 to $0.59 per share, inclusive.
3 Common Common Stock 2025-05-16 P A 172,314 $0.45 556,338 D — — (F1) The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. (F2) Purchase prices range from $0.4485 to $0.4564 per share, inclusive.